CN114712517B - 一种泊洛沙姆外用凝胶剂及其制备方法 - Google Patents
一种泊洛沙姆外用凝胶剂及其制备方法 Download PDFInfo
- Publication number
- CN114712517B CN114712517B CN202210486310.3A CN202210486310A CN114712517B CN 114712517 B CN114712517 B CN 114712517B CN 202210486310 A CN202210486310 A CN 202210486310A CN 114712517 B CN114712517 B CN 114712517B
- Authority
- CN
- China
- Prior art keywords
- poloxamer
- solution
- root extract
- turmeric root
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 title claims abstract description 72
- 229920001983 poloxamer Polymers 0.000 title claims abstract description 62
- 229960000502 poloxamer Drugs 0.000 title claims abstract description 62
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 238000001879 gelation Methods 0.000 title description 2
- 239000002454 curcuma longa l. root extract Substances 0.000 claims abstract description 55
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 52
- 238000003756 stirring Methods 0.000 claims abstract description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000004530 micro-emulsion Substances 0.000 claims abstract description 31
- 241000264279 Sargassum fusiforme Species 0.000 claims abstract description 26
- 150000004676 glycans Chemical class 0.000 claims abstract description 26
- 239000004310 lactic acid Substances 0.000 claims abstract description 26
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 26
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 26
- 239000005017 polysaccharide Substances 0.000 claims abstract description 26
- 239000000243 solution Substances 0.000 claims description 86
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 63
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 56
- 239000000203 mixture Substances 0.000 claims description 54
- 239000000839 emulsion Substances 0.000 claims description 34
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 28
- 229920000359 diblock copolymer Polymers 0.000 claims description 25
- 239000007864 aqueous solution Substances 0.000 claims description 20
- 239000000693 micelle Substances 0.000 claims description 20
- 238000009210 therapy by ultrasound Methods 0.000 claims description 18
- 241000407170 Curcuma Species 0.000 claims description 16
- 235000014375 Curcuma Nutrition 0.000 claims description 16
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 16
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 12
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 229920001992 poloxamer 407 Polymers 0.000 claims description 10
- 229940044476 poloxamer 407 Drugs 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000006185 dispersion Substances 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 5
- 238000001704 evaporation Methods 0.000 claims description 2
- 231100000241 scar Toxicity 0.000 abstract description 39
- 230000000694 effects Effects 0.000 abstract description 8
- 230000008485 antagonism Effects 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 208000032544 Cicatrix Diseases 0.000 abstract description 2
- 125000000686 lactone group Chemical group 0.000 abstract description 2
- 229920000642 polymer Polymers 0.000 abstract description 2
- 230000037387 scars Effects 0.000 abstract description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 21
- 230000000052 comparative effect Effects 0.000 description 11
- 230000008439 repair process Effects 0.000 description 11
- 238000010612 desalination reaction Methods 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 230000036573 scar formation Effects 0.000 description 9
- 238000009423 ventilation Methods 0.000 description 9
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000012986 chain transfer agent Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 125000003473 lipid group Chemical group 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000007908 nanoemulsion Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- SVYHMICYJHWXIN-UHFFFAOYSA-N 2-[di(propan-2-yl)amino]ethyl 2-methylprop-2-enoate Chemical compound CC(C)N(C(C)C)CCOC(=O)C(C)=C SVYHMICYJHWXIN-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- VSGGRAHIYGZCAO-UHFFFAOYSA-N CCCCCCCCCCCCC(=S)SC(C)(CCC(O)=O)C#N Chemical compound CCCCCCCCCCCCC(=S)SC(C)(CCC(O)=O)C#N VSGGRAHIYGZCAO-UHFFFAOYSA-N 0.000 description 1
- 241000759905 Camptotheca acuminata Species 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000000315 cryotherapy Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- PIVLVFMHHKIDED-UHFFFAOYSA-N n,n'-dicyclohexylmethanediimine;1-hydroxypyrrolidine-2,5-dione Chemical compound ON1C(=O)CCC1=O.C1CCCCC1N=C=NC1CCCCC1 PIVLVFMHHKIDED-UHFFFAOYSA-N 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 229920000428 triblock copolymer Polymers 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
实施例1 | 实施例2 | 实施例3 | 实施例4 | 实施例5 | 对比例1 | 对比例2 | 对比例3 | 对比例4 | |
瘢痕情况 | 不明显 | 不明显 | 不明显 | 不明显 | 不明显 | 较明显 | 较明显 | 明显 | 明显 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210486310.3A CN114712517B (zh) | 2022-05-06 | 2022-05-06 | 一种泊洛沙姆外用凝胶剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210486310.3A CN114712517B (zh) | 2022-05-06 | 2022-05-06 | 一种泊洛沙姆外用凝胶剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114712517A CN114712517A (zh) | 2022-07-08 |
CN114712517B true CN114712517B (zh) | 2023-07-25 |
Family
ID=82232253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210486310.3A Active CN114712517B (zh) | 2022-05-06 | 2022-05-06 | 一种泊洛沙姆外用凝胶剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114712517B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102614107A (zh) * | 2012-03-26 | 2012-08-01 | 中国人民解放军第二军医大学 | 一种皮肤外用微乳温敏凝胶剂及其制法 |
KR101972085B1 (ko) * | 2018-09-17 | 2019-04-24 | (주)에이씨티 | 강황 추출물의 안정화 방법 및 안정화된 강황추출물을 함유하는 화장료 조성물 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1588697A1 (en) * | 2004-04-16 | 2005-10-26 | Kurt H. Prof. Dr. Bauer | Emulsion gel for topical application of pharmaceuticals |
CN101212952B (zh) * | 2005-05-27 | 2012-02-08 | 株式会社林原生物化学研究所 | 皮肤外用剂 |
CN108904522A (zh) * | 2018-08-09 | 2018-11-30 | 江南大学 | 一种肝素衍生物-泊洛沙姆温敏型水凝胶及其制备方法 |
CN111603441B (zh) * | 2020-07-01 | 2022-11-25 | 瑞希(重庆)生物科技有限公司 | 一种两亲性聚氨基酸共聚物/泊洛沙姆温敏凝胶及其制备方法 |
CN111759800A (zh) * | 2020-08-14 | 2020-10-13 | 广东海洋大学 | 一种姜黄素包合物温敏性凝胶及其制备方法与应用 |
-
2022
- 2022-05-06 CN CN202210486310.3A patent/CN114712517B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102614107A (zh) * | 2012-03-26 | 2012-08-01 | 中国人民解放军第二军医大学 | 一种皮肤外用微乳温敏凝胶剂及其制法 |
KR101972085B1 (ko) * | 2018-09-17 | 2019-04-24 | (주)에이씨티 | 강황 추출물의 안정화 방법 및 안정화된 강황추출물을 함유하는 화장료 조성물 |
Also Published As
Publication number | Publication date |
---|---|
CN114712517A (zh) | 2022-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69530004T2 (de) | Transdermale verabreichung von apomorphin | |
CN102264351B (zh) | 包含水溶性差的药物的聚合胶束组合物的制备方法 | |
CA2002404A1 (en) | Delivery system for pharmaceutical or therapeutic actives | |
EP1800694A1 (en) | Controlled release gels | |
CN112022919A (zh) | 经皮吸收的苍艾油传递体凝胶及其制备方法 | |
CN110870868A (zh) | 包含亚甲蓝类染料、营养素或/和抗肿瘤化合物的药物组合物及其应用 | |
CN105708789A (zh) | 一种载药纳米纤维微球/水凝胶复合物及其制备方法和应用 | |
KR20130143288A (ko) | 흉터 치료용 피부외용제 조성물 | |
CN114712517B (zh) | 一种泊洛沙姆外用凝胶剂及其制备方法 | |
CN104288093A (zh) | 纳米药物透皮制剂在肿瘤中的应用 | |
CN101658495B (zh) | 一种氢溴酸高乌甲素固体脂质纳米粒及其制备方法 | |
KR102560150B1 (ko) | 트러블 개선 및 피부 재생을 위한 용해성 미세바늘 패치 | |
CN102766267A (zh) | 一种含磁性纳米粒子的壳聚糖水凝胶的制备方法 | |
CN113332232B (zh) | 一种含虎杖苷的组合物及其应用 | |
CN109627459A (zh) | 一种可注射氧化透明质酸水凝胶及其制备方法 | |
CN112190567B (zh) | 一种伊维菌素缓释微球的制备方法及应用 | |
CN112263544B (zh) | 一种盐酸利多卡因凝胶及其制备方法 | |
KR960008315B1 (ko) | 외용 겔 기제 | |
KR20230118632A (ko) | 암을 치료하기 위한 물질 및 방법 | |
CN112245383B (zh) | 一种抗癌症的经皮吸收制剂 | |
Almoshari | Novel Hydrogels for Topical Applications: An Updated Comprehensive Review Based on Source. Gels 2022, 8, 174 | |
CN109303918A (zh) | 可用于透皮给药的氰基丙烯酸酯及其组合物 | |
CN111374937B (zh) | 一种用于婴幼儿血管瘤凝胶及其制备方法 | |
CN111265594A (zh) | 用于修复伤口的药物制剂及制备方法 | |
CN111202849B (zh) | 一种白蛋白结合型亚硝基脲类抗肿瘤药物制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240311 Address after: No. 3388, Baocheng Road, Beihu science and Technology Development Zone, Changchun City, Jilin Province Patentee after: Jilin Lanpu Haoye Technology Co.,Ltd. Country or region after: China Address before: 130102 room 106, No. 3398, Baocheng Road, Beihu science and Technology Development Zone, Changchun City, Jilin Province Patentee before: Lanke Yimei science and Technology (Jilin) Co.,Ltd. Country or region before: China |